Anavex Life Sciences Corp (AVXL)

[Gernee20]

According to Clinicaltrials.gov (https://clinicaltrials.gov/ct2/show/NCT03790709?term=Anavex+2-73&cond=Alzheimer+Disease+3&draw=2&rank=1) the high dose AD study is Phase 2 and the mid dose AD study is Phase 3

Where are you seeing the different doses are linked to either ph2 or ph3?

A great question at the annual meeting would be to ask Missling to clarify this, to discuss whether the Phase 3 portion (mid dose) is (or could be) a pivotal trial and how long it would take to crunch and report the data.

During a call in 2019, Missling said he would review the data with authorities. However, the donepezil trial was stopped early, I think if we are seeing clear positive data and strong signal, our AD trial would be considered pivotal regardless of what Missling has or hasn't said.

It'll take 6-9 months to crunch all the data, put it into a reportable format, and present the data in an appropriate scientific forum.

6-9 months to crunch and present data? We aren't scribing on rocks here.